Gladius Capital Management’s Theravance Biopharma TBPH Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-3,190	Closed	-$34.6K	–	381
2023 Q1	$34.6K	Sell	3,190 -363	-10%	-$3.94K	﹤0.01%	178
2022 Q4	$39.9K	Buy	+3,553	New	+$39.9K	﹤0.01%	170